These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Does remote ischaemic preconditioning with postconditioning improve clinical outcomes of patients undergoing cardiac surgery? Remote Ischaemic Preconditioning with Postconditioning Outcome Trial. Hong DM; Lee EH; Kim HJ; Min JJ; Chin JH; Choi DK; Bahk JH; Sim JY; Choi IC; Jeon Y Eur Heart J; 2014 Jan; 35(3):176-83. PubMed ID: 24014392 [TBL] [Abstract][Full Text] [Related]
31. Impact of atrial fibrillation in patients with ST-elevation myocardial infarction treated with percutaneous coronary intervention (from the HORIZONS-AMI [Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction] trial). Rene AG; Généreux P; Ezekowitz M; Kirtane AJ; Xu K; Mehran R; Brener SJ; Stone GW Am J Cardiol; 2014 Jan; 113(2):236-42. PubMed ID: 24176066 [TBL] [Abstract][Full Text] [Related]
32. Open-label, randomized, placebo-controlled evaluation of intracoronary adenosine or nitroprusside after thrombus aspiration during primary percutaneous coronary intervention for the prevention of microvascular obstruction in acute myocardial infarction: the REOPEN-AMI study (Intracoronary Nitroprusside Versus Adenosine in Acute Myocardial Infarction). Niccoli G; Rigattieri S; De Vita MR; Valgimigli M; Corvo P; Fabbiocchi F; Romagnoli E; De Caterina AR; La Torre G; Lo Schiavo P; Tarantino F; Ferrari R; Tomai F; Olivares P; Cosentino N; D'Amario D; Leone AM; Porto I; Burzotta F; Trani C; Crea F JACC Cardiovasc Interv; 2013 Jun; 6(6):580-9. PubMed ID: 23683738 [TBL] [Abstract][Full Text] [Related]
33. Use of ranolazine in patients with incomplete revascularization after percutaneous coronary intervention: design and rationale of the Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (RIVER-PCI) trial. Weisz G; Farzaneh-Far R; Ben-Yehuda O; Debruyne B; Montalescot G; Lerman A; Mahmud E; Alexander KP; Ohman EM; White HD; Olmsted A; Walker GA; Stone GW Am Heart J; 2013 Dec; 166(6):953-959.e3. PubMed ID: 24268208 [TBL] [Abstract][Full Text] [Related]
34. Prognostic impact of periprocedural bleeding and myocardial infarction after percutaneous coronary intervention in unselected patients: results from the EVENT (evaluation of drug-eluting stents and ischemic events) registry. Lindsey JB; Marso SP; Pencina M; Stolker JM; Kennedy KF; Rihal C; Barsness G; Piana RN; Goldberg SL; Cutlip DE; Kleiman NS; Cohen DJ; JACC Cardiovasc Interv; 2009 Nov; 2(11):1074-82. PubMed ID: 19926047 [TBL] [Abstract][Full Text] [Related]
35. The impact of distal embolization and distal protection on long-term outcome in patients with ST elevation myocardial infarction randomized to primary percutaneous coronary intervention--results from a randomized study. Lønborg J; Kelbæk H; Helqvist S; Holmvang L; Jørgensen E; Saunamäki K; Kløvgaard L; Kaltoft A; Bøtker HE; Lassen JF; Thuesen L; Terkelsen CJ; Kofoed KF; Clemmensen P; Køber L; Engstrøm T Eur Heart J Acute Cardiovasc Care; 2015 Apr; 4(2):180-8. PubMed ID: 25013089 [TBL] [Abstract][Full Text] [Related]
36. Safety and feasibility of adjunctive antiplatelet therapy with intravenous elinogrel, a direct-acting and reversible P2Y12 ADP-receptor antagonist, before primary percutaneous intervention in patients with ST-elevation myocardial infarction: the Early Rapid ReversAl of platelet thromboSis with intravenous Elinogrel before PCI to optimize reperfusion in acute Myocardial Infarction (ERASE MI) pilot trial. Berger JS; Roe MT; Gibson CM; Kilaru R; Green CL; Melton L; Blankenship JD; Metzger DC; Granger CB; Gretler DD; Grines CL; Huber K; Zeymer U; Buszman P; Harrington RA; Armstrong PW Am Heart J; 2009 Dec; 158(6):998-1004.e1. PubMed ID: 19958867 [TBL] [Abstract][Full Text] [Related]
37. Rationale and design of the MGuard for acute ST elevation reperfusion MASTER trial. Costa JR; Abizaid A; Dudek D; Silber S; Leon MB; Stone GW Catheter Cardiovasc Interv; 2013 Aug; 82(2):184-90. PubMed ID: 23008177 [TBL] [Abstract][Full Text] [Related]
38. Radial versus femoral access for primary percutaneous interventions in ST-segment elevation myocardial infarction patients: a meta-analysis of randomized controlled trials. Karrowni W; Vyas A; Giacomino B; Schweizer M; Blevins A; Girotra S; Horwitz PA JACC Cardiovasc Interv; 2013 Aug; 6(8):814-23. PubMed ID: 23968700 [TBL] [Abstract][Full Text] [Related]
39. Management and outcome of patients with established coronary artery disease: the Euro Heart Survey on coronary revascularization. Lenzen MJ; Boersma E; Bertrand ME; Maier W; Moris C; Piscione F; Sechtem U; Stahle E; Widimsky P; de Jaegere P; Scholte op Reimer WJ; Mercado N; Wijns W; Eur Heart J; 2005 Jun; 26(12):1169-79. PubMed ID: 15802360 [TBL] [Abstract][Full Text] [Related]
40. Efficacy of high-dose atorvastatin loading before primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: the STATIN STEMI trial. Kim JS; Kim J; Choi D; Lee CJ; Lee SH; Ko YG; Hong MK; Kim BK; Oh SJ; Jeon DW; Yang JY; Cho JR; Lee NH; Cho YH; Cho DK; Jang Y JACC Cardiovasc Interv; 2010 Mar; 3(3):332-9. PubMed ID: 20298994 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]